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PROGRAMME
2.00 pm  Welcome
2.15pm  Presented Abstracts
3.15pm  Invited  Abstract:  Is  there  a  place  for  liver 
transplantation  from  living  donors?  Dr  John  O’Grady, 
Consultant Hepatologist, Liver Unit, Kings College Hospital, 
London.
3.40pm Tea/Coffee
4.00pm  Presented Abstracts
4.35pm  Guest  Lecture:  Prospects  for  stem  cell  therapy 
in  cardiac  regeneration. Prof  Tim  O’Brien,  Director, 
Regenerative  Medicine  Institute,  National  University  of 
Ireland, Galway.
5.30pm  Close
PRESENTED ABSTRACTS
Use of Estimated Glomerular Filtration Rate (eGFR) To Guide Nephrological 
Referral for Patients with Stage 4 Chronic Kidney Disease (CKD): Service 
Implications.
B Conway,1 D Fogarty,2 P McKeveney,1 J Harty,1  K Sinnamon.1
1 Nephrology Unit, Daisy Hill Hospital, Newry, BT35 8DR, United Kingdom 
and 2 Department of Nephrology, Belfast City Hospital, 51 Lisburn Road, 
Belfast BT9 7AB, United Kingdom.
Current  guidelines  recommend  nephrology  referral  when 
eGFR  <30mls/min. To  determine  the  implications  of  this 
guideline on our nephrology unit which serves the Southern 
Health and Social Services Board (SHSSB) area of Northern 
Ireland (population 320, 000) we identified: (i) the number of 
patients in this area with an eGFR of 15-29 mls/min (stage 
4 CKD) (ii) the factors influencing outcomes (dialysis or 
death) in this group.
Laboratory tests of renal function performed in 2001 were 
screened to identify all patients with an eGFR of 15-29 mls/
min. An electronic database identified all patients referred to 
our unit between June 1998 and December 2000 with stage 
4 CKD. Baseline and follow–up data including eGFR, 24hr 
proteinuria, blood pressure and death or need for dialysis was 
obtained.
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In 2001, 1,730 patients with stage 4 CKD were identified, of 
whom 176 (10.2%) were known to the nephrology service. 
Between June 1998 and December 2000, 95 patients were 
referred with CKD stage 4, of whom 25% required dialysis 
within  5  years.  This  group  had  a  lower  baseline  mean 
eGFR (21.0 vs.24.9mls/min, p=0.0001) and a higher mean 
proteinuria  (2.42  vs.  0.81g/dL,  p=0.01)  than  those  who 
remained dialysis-independent. 50%, 33% and 9% of patients 
with  baseline  eGFR  of  15-19,  20-24  and  25-29  mls/min 
respectively required dialysis. Currently guidelines require 
nephrological referral for a large number of persons, of whom 
only 25% require dialysis within 5 years. Future guidelines 
should focus on a demonstrated decline in eGFR and level of 
proteinuria rather than a threshold level of eGFR.
The MEF2A gene and ischaemic heart disease in Ireland.
PG  Horan,1  AR  Allen,2  AE  Hughes,3  CC  Patterson,4 MS  Spence,1  PG 
McGlinchey,1 C Belton,2 PP McKeown.1, 2
1 Regional Medical Cardiology Centre, Royal Victoria Hospital, Grosvenor 
Road, Belfast, BT12 6BA, Northern Ireland, UK.
2 Department of Medicine, Queen’s University Belfast, Institute of Clinical 
Science, Grosvenor Road, Belfast, BT12 6BJ, Northern Ireland, UK.
3  Department  of  Medical  Genetics,  Queen’s  University  Belfast,  Royal 
Victoria Hospital, Grosvenor Road, Belfast, BT12 6BJ, Northern Ireland, 
UK.
4  Department  of  Epidemiology  and  Public  Health,  Queen’s  University 
Belfast, Mulhouse Building, Grosvenor Road, Belfast, BT12 6BJ, Northern 
Ireland, UK.
Ischaemic heart disease (IHD) is a complex disease due to 
the combination of environmental and genetic factors. The 
MEF2A gene codes for an important protein in myocardial 
muscle development. In a large US family a 21bp deletion 
(∆7aa)  was  reported  to  be  associated  with  IHD  with  an 
autosomal  dominant  pattern  of  inheritance  (Wang  et  al. 
Science, 2003). We investigated this region of the MEF2A 
gene  using  an  Irish  family-based  study,  where  affected 
individuals had early-onset IHD.
A total of 1494 individuals from 580 families were included 
(800  discordant  sib-pairs  and  64  parent-child  trios).  The 
∆7aa region of the MEF2A gene was investigated based on 
amplicon size.
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The  ∆7aa  mutation  was  not  detected  in  any  individual. 
Coincidentally, considerable variation in the number of CAG 
(glutamate) and CCG (proline) residues was detected in a 
nearby region. However, this was not found to be associated 
with IHD.
The ∆7aa mutation was not detected in any individual within 
the study population and is unlikely to play a significant role 
in the development of IHD in Ireland. Using family-based 
tests of association the number of tri-nucleotide repeats in a 
nearby region of the MEF2A gene was not associated with 
IHD in our study group.
Comparison  of  cardiovascular  risk  factors  in  rheumatoid 
arthritis and osteoporosis
DJ Armstrong,1 EMA McCausland,1 ASH Lee,1 A Quinn,1 M McQuilkin,2 
GD Wright,1 MB Finch.1
1 Department of Rheumatology, Royal Victoria Hospital, Belfast. 
2 Department of Rheumatology, Musgrave Park Hospital, Belfast.
There  is  increasing  awareness  of  the  importance  of 
cardiovascular risk control in rheumatoid disease, and more 
recently  speculation  that  osteoporosis  may  also  carry  an 
increased risk of atherosclerotic disease.
We  performed  a  comprehensive  risk  analysis  on  100 
rheumatoid  arthritis  (RA)  patients  (20  male,  80  female, 
median age 60.0 years 95%CI 57.0-62.0) and 30 primary 
osteoporosis patients (3 male, 27 female, median age 67.5 
years, 95%CI 62.8-70.0) in the outpatient setting. 8% of RA 
patients had a personal history of MI or stroke, compared with 
none of the osteoporosis cohort, although only 62% of RA 
had a BP check in the last year, and 28% a fasting cholesterol 
check,  compared  with  83%  and  47%  in  osteoporosis 
patients.
17% of both RA and osteoporosis patients had systolic BP 
>160mmHg, and 17% and 18% respectively diastolic BP 
>90mmHg. There  was  an  interesting  correlation  between 
diastolic  BP  and  low  trauma  fracture  in  the  osteoporotic 
patients  (r=0.56,  p<0.01),  and  between  diastolic  BP  and 
BMI in RA patients (r=0.37, p<0.01). HDL:cholesterol ratio 
correlated  with  BMD  at  spine  in  the  osteoporosis  group 
(r=0.51,  p=0.01).  57%  of  osteoporosis  patients,  and  54% 
of RA patients had fasting cholesterol levels >5.2. 4 RA 
patients and none of the osteoporosis patients were taking 
lipid-lowering drugs.
Conclusion: Levels of cardiovascular risk were similar in 
both RA, a disease with known accelerated atherosclerosis, 
and osteoporosis, although monitoring appeared better in the 
osteoporosis group. Despite this, a substantial unmet need 
remains. A possible correlation between cardiovascular risk 
factors and bone health requires further investigation.
Diet  and  insulin  resistance:  comparison  of  high  and  low 
sucrose diets, a randomised controlled trial.
RNA Black, M Spence,2 GJ Cuskelly,2 CN Ennis,1 DR McCance,1 IS Young,2 
PM Bell,1 SJ Hunter.1
1 Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, 
Grosvenor Road, Belfast  BT12 6BA.
2 Department of Medicine, Queen’s University Belfast, BT12 6BJ.
The long-term impact of dietary carbohydrate, in particular 
sucrose, on insulin resistance and the development of diabetes 
and  atherosclerosis  is  not  established.  Current  guidelines 
advise restriction of sucrose intake to 10% of total energy 
intake.
We investigated the effect of a high versus low sucrose diet 
(25% versus 10% of total energy intake). Thirteen healthy 
male volunteers, aged 34 ± 3 years (mean ± SEM), BMI 26.7 
± 0.9kg/m2 were included in a randomised crossover design 
with sequential 6-week dietary interventions separated by 
4-week wash-out.
Weight maintenance diets with constant macronutrient profiles 
and fibre content were designed.  Subjects were monitored 
and all food was weighed and distributed 3-5 times weekly.   
Insulin action was assessed using a 2-step euglycaemic clamp 
and the isotope dilution method (3-3H glucose) was used 
to  determine  glucose  utilisation  and  endogenous  glucose 
production rates.
There was no change in weight or physical activity during the 
study period. Suppression of endogenous glucose production 
was similar after each diet. At an insulin infusion rate of 2mU/
kg/min, the peripheral glucose utilisation after 25% sucrose 
diet was 57.0 ± 4.9 mmol/kg/min compared to 47.6 ± 3.6 
mmol/kg/min after a 10% sucrose diet, p=NS.
In this study, a high-sucrose intake as part of a eucaloric, 
weight-maintaining diet had no detrimental effect on insulin 
sensitivity  in  healthy  non-diabetic  subjects. These  results 
suggest that than carbohydrate quality may be a less important 
determinant of insulin action than caloric excess, physical 
activity or weight gain.
Takotsubo cardiomyopathy: an uncommon cause of acute ST-
segment elevation on the 12 lead electrocardiogram
D McCarty,1 CH Courtney,2 B Mullan,3 NPS Campbell,1 CM  Wilson.1
1 Regional Medical Cardiology Centre, Royal Victoria Hospital, Belfast.
2 Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, 
Belfast.
3  Regional Intensive Care Unit, Royal Victoria Hospital, Belfast.
A  63  year  old  female  was  admitted  with  a  three  month 
history of increasing lethargy, anorexia, diarrhoea, weight 
loss,  depression  and  confusion.  Past  medical  history 
included  hypertension,  cerebrovascular  disease,  heavy 
smoking and alcohol abuse. On clinical examination she was 
dehydrated, malnourished and disorientated. Initial laboratory 
investigations demonstrated anemia and thrombocytopenia. A 
profound hypokalemic hypochloremic metabolic alkalosis was 
present. Proteinuria was noted. Chest radiograph was normal. 
Electrocardiography demonstrated a prolonged corrected QT 
interval. Treatment with empirical intravenous antibiotics, 
electrolyte  replacement,  red  cell  and  platelet  transfusion 
was instituted. Computed tomography of brain, cardiac and 
abdominal ultrasonography were initially normal. On the sixth 
day following admission the patient developed fluid overload 
with type I respiratory failure and radiographical evidence of 
pulmonary oedema. She was transferred for intensive care ©  The Ulster Medical Society, 2006.
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and required intravenous antibiotics, diuretics, non-invasive 
ventilation and inotropic support.
On  the  tenth  day  the  patient  deteriorated  acutely.  Repeat 
electrocardiography  revealed  ST-elevation  consistent 
with  acute  inferoposterolateral  myocardial  infarction. 
Echocardiography demonstrated corresponding wall motion 
abnormalities. Emergency coronary angiography revealed no 
causative atherosclerotic, thrombotic, embolic or vasospastic 
lesion.  Left  ventriculography  showed  inferoposterolateral 
akinesia in keeping with Takotsubo cardiomyopathy.
Takotsubo  cardiomyopathy  is  a  recently  recognised  cause 
of acute reversible left ventricular systolic dysfunction. The 
condition typically affects elderly females and presents with 
clinical and electrocardiographic features mimicking acute 
myocardial infarction. A characteristic ventricular wall motion 
abnormality (apical ballooning) is observed. The condition is 
often associated with acute physical or psychological stress 
and may result from catecholamine excess. Patients surviving 
the acute phase tend to recover spontaneously.
Type 1 diabetes and road traffic incidents: a case control 
study.
M Tohill,1 SJ Hunter,2 C Patterson,3 AB Stevens.1
1 Risk and Occupational Health Department, the Royal Hospitals, Belfast.  
2 Regional Centre for Diabetes and Endocrinology, the Royal Hospitals, 
Belfast.  
3 Department  of  Epidemiology  and  Public  Health,  Queens  University, 
Belfast.
Type 1 diabetes in drivers of motor vehicles is assumed to 
be a hazard for road safety. Identification of particular risk 
factors may enable preventive strategies. We performed a 
case referent study to identify factors linked to road traffic 
incidents in drivers with type 1 diabetes.
An initial postal questionnaire was sent to a population of 942 
patients with type 1 diabetes mellitus attending the Diabetes 
clinic at the Royal Victoria Hospital, Belfast. Four hundred 
and eighty two responders included 311 eligible participants 
and 171 who were ineligible. Structured telephone interviews 
were undertaken with the 311, identifying 92 cases (who had 
a road traffic incident in the past 2 years) and 219 referents.
Following multivariate analysis, risk factors for road traffic 
incidents were the absence of awareness of hypoglycaemic 
symptoms  (OR  44.2,  p<0.001),  the  presence  of  only 
neuroglycopaenic  symptoms  of  hypoglycaemia  (OR  7.4, 
p<0.01), higher insulin dose (OR 5.3, p<0.01), a frequency 
of driving 5+ times per day (OR 5.6, p<0.001), a history 
of having a previous hypoglycaemic episode while driving 
without taking sugar (OR 22.6, p<0.01) and being on a Beta 
Blocker (OR 6.1, p<0.01). Higher HbA1C level was protective 
(OR 0.3, p<0.001), as was testing blood sugar before driving 
(OR 0.2, p<0.001).
In conclusion the results demonstrate that intensive blood 
glucose  management,  hypoglycaemia  unawareness  and 
frequent driving are risk factors for road traffic incidents. 
Patients, clinicians and occupational physicians should be 
aware of these risk factors and of the protective value of self 
blood glucose monitoring before driving.
Use  of  N-Terminal-pro-Brain  Natriuretic  Peptide  in  the 
Diagnosis of Ischaemic Heart Disease in Patients Presenting 
to a Rapid Access Chest Pain Clinic.
AR Muir, J Neill, J Dougan, AAJ Adgey, Department of Cardiology, Royal 
Victoria Hospital, Belfast.
N-terminal-pro-BNP (NT-pro-BNP) is a proven diagnostic 
marker of congestive heart failure and predictor of recurrent 
ischaemic events and mortality in both stable and unstable 
ischaemic heart disease (IHD).1, 2 
We hypothesized that NT-pro-BNP may be a useful diagnostic 
marker  for  IHD  in  patients  presenting  with  previously 
undiagnosed chest pain to a rapid access chest pain clinic. 
NT-pro-BNP  was  compared  as  a  diagnostic  marker  to 
standard risk stratification methods combined with exercise 
stress testing. Positive diagnosis ranged from acute coronary 
syndrome to possible IHD requiring further investigation.
447  consecutive  patients  were  studied.  NT-pro-BNP  was 
significantly  higher  among  those  diagnosed  with  IHD 
versus non-IHD (95ng/L [interquartile range 44 to 199] vs 
43ng/L  [interquartile  range  22  to  72]  p=0.029).  Patients 
in the highest NT-pro-BNP quartile were older, had lower 
creatinine  clearance  and  more  cardiovascular  risk  factors 
than those in the lowest quartile. Those in the highest quartile 
were statistically significantly more likely to have a positive 
exercise stress test (EST) (p<0.001).
Following  logistic  regression  analysis,  NT-pro-BNP  in 
the highest quartile was predictive of a diagnosis of IHD, 
independent of standard risk factor profile and biochemical 
markers  including  creatinine  clearance  and  troponin  I 
(p=0.001). After inclusion of EST result in the regression 
model, no NT-pro-BNP quartile was a significant predictor 
of IHD (p=0.988).
In the setting of a rapid access chest pain clinic, NT-pro-
BNP quartile does not improve IHD diagnosis more than an 
EST. It may be a useful prognostic indicator of morbidity and 
mortality in this group, and follow up data will be useful.
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